Related Articles
Splice variants of lysosome‑associated membrane proteins 2A and 2B are involved in sunitinib resistance in human renal cell carcinoma cells
QPCT regulation by CTCF leads to sunitinib resistance in renal cell carcinoma by promoting angiogenesis
Different immunological effects of the molecular targeted agents sunitinib, everolimus and temsirolimus in patients with renal cell carcinoma
Application of natural killer cells in pancreatic cancer (Review)
GLI2 expression levels in radical nephrectomy specimens as a predictor of disease progression in patients with metastatic clear cell renal cell carcinoma following treatment with sunitinib